Newsroom

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today presented the most contemporary analysis of the HELIOS-B Phase 3 study of vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) as a late-breaking abstract at the Heart Failure 2025 Congress, a scientific congress of the European Society of Cardiology, taking place May 17-20 in Belgrade, Serbia. The results demonstrate that vutrisiran, which rapi...

MAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its third mission for Japanese customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS). ‘The Sea God Sees’ mission successfully launched on Electron from Rocket Lab Launch Complex 1 in Mahia, New Zealand at 8:17 p.m. NZT on May 17th, 2025. The mission carried iQPS’ QPS-SAR-10, a synthetic aperture radar (...

MALVERN, Pa., & TOKYO--(BUSINESS WIRE)--Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the...

ROSEMEAD, Calif.--(BUSINESS WIRE)--The entire Edison International, Southern California Edison and Trio community is deeply saddened to learn of the passing of John Bryson, who served as Edison International’s chairman and CEO from 1990 to 2008. John passed away Tuesday, May 13 at age 81. He was a groundbreaking leader whose remarkable career ranged from a founding role in the environmental movement to public service as the U.S. Secretary of Commerce. “Our industry has lost a true legend, and I...

TORONTO--(BUSINESS WIRE)--Flow Beverage Corp. (TSX:FLOW; OTCQX:FLWBF) (“Flow” or the “Company”) announced today that RI Flow LLC (“RI Flow”) has extended the maturity date of the Term Loan (“the RI Flow Loan”) to October 31, 2025. The Company also announced today that RI Flow LLC has irrevocably waived any rights and remedies in relation to certain breaches by the Company under the RI Flow Loan and Security Agreement dated October 31, 2024. Separately, NFS Leasing Canada Ltd. (“NFS”) has irrevo...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NV5 Global, Inc. (NasdaqGS: NVEE) to Acuren Corporation (NYSE: TIC). Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren, subject to adjustment. KSF is seeking to determine...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Charter Communications, Inc. (NasdaqGS: CHTR) and Cox Communications. Upon closing of the proposed transaction, Cox Enterprises will own approximately 23% of the combined entity's fully diluted shares outstanding, on an as-converted, as-exchanged basis, and pro forma for the closing of the Liberty...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have until July 15, 2025 to file lead plaintiff applications in a securities class action lawsuit against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NasdaqGM: IOVA), if they purchased the Company’s securities between May 9, 2024 and May 8, 2025, inclusive (the “Class...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company’s previously announced $16 million offering that was announced on May 15, 2025. The o...

LADERA RANCH, Calif.--(BUSINESS WIRE)--Strategic Storage Trust VI, Inc. (“SST VI”) announced operating results for the three months ended March 31, 2025. "This quarter marks an important milestone for our company as we report our first same-store results." commented H. Michael Schwartz, President and CEO of Strategic Storage Trust VI, Inc. "I'm pleased to share that these results exceeded our expectations and reflect the underlying strength and quality of our portfolio across both the United St...